Two-phase scintigraphy with technetium 99m-sestamibi in patients with hyperparathyroidism due to chronic renal failure

American Journal of Surgery

Volumn 193, Issue 4, 2007, Pages 438-442

  Muros, Maria A ^a   Soto, Juan Bravo ^a   López Ruiz, José M ^a   Rodríguez Portillo, Mariano ^b   Ramírez Navarro, Angel ^a   Bellón Guardia, María ^a   Perán, Fernando ^a   Llamas Elvira, Jose M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Parathyroid gland hyperplasia; Renal hyperparathyroidism; Sestamibi scintigraphy

Indexed keywords

CALCIUM; CREATININE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; FUNCTIONAL ANATOMY; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; MALE; ORGAN WEIGHT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; RADIOISOTOPE DIAGNOSIS; RETROSPECTIVE STUDY; TISSUE DISTRIBUTION;

ADULT; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID GLANDS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI;

EID: 33947161025     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.08.078     Document Type: Article

References (24)

1. O′Doherty M.J., and Kettle A.G. Parathyroid imaging: preoperative localization. Nucl Med Commun 24 (2003) 125-131
2. Hindie E., Urena P., Jeanguillaume C., et al. Preoperative imaging of parathyroid glands with technetium99m labeled sestamibi and iodine 123 subtraction scanning in secondary hyperparathyroidism. Lancet 353 (1999) 2200-2204
3. Berczi C., Mezosi E., Galuska L., et al. Technetium 99m-sestamibi/ pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism. Eur Radiol 12 (2002) 605-609
4. Rubello D., Casara D., and Pelizzo M.R. Optimization of preoperative procedures. Nucl Med Commun 24 (2003) 133-140
5. 99mTc-methoxyisobutilisonitrile imaging for parathyroid adenoma: Relationship tp P-glycoprotein or multidrug resistence-related protein espression. Eur J Nucl Med Mol Imaging 29 (2002) 1012-1015
6. Ishibashi M., Nishida H., Okuda S., et al. Localization of parathyroid glands in hemodialysis patients using 99mTc sestamibi imaging. Nephrol Dial Transplant 13 suppl 3 (1998) 103-104
7. Pons F., Torregrosa J.V., and Fuster D. Biological factors influencing parathyroid localization. Nucl Med Commun 24 (2003) 121-124
8. Torregrosa J.V., Palomar M.R., Pons F., et al. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism?. Nephrol Dial Transplant 13 suppl 3 (1998) 37-40
9. 99mTc-MIBI scintigraphy. Nippon Hinyokika Gakkai Zasshi 88 (1997) 795-800
10. Wada A., Sugihara M., Sugimura K., et al. Magnetic resonance imaging (MRI) and technetium 99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism. Med Imag Radiat Oncol 17 (1999) 275-282
11. Yamaguchi S., Yachiku S., Hashimoto H., et al. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the paarathyroid glands. World J Surg 26 (2002) 29-34
12. 99mtc-Sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metabol 83 (1998) 3867-3871
13. Parfitt A.M. Parathyroid growth: normal and abnormal. In: Bilezikian J.P., Marcus R., and Levine M.A. (Eds). The Parathyroid. 2th ed. (2001), Academic Press, San Diego, CA 293-331
14. Silver J. Pathogenesis of parathyroid dysfunction in end-stage renal disease. Adv Renal Replace Ther 3 (2002) 159-167
15. 99mTc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 24 (2000) 1386-1390
16. Goldstein R.E., Billheimer D., Martin W.H., et al. Sestamibi scanning and minimally invasive radioguided surgery without intraoperative parathyroid hormone measurement. Ann Surg 237 (2003) 722-730
17. Torregrosa J.V., Palomar R., Pons F., et al. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism?. Nephrol Dial Transplant 13 suppl 3 (1998) 37-40
18. Cermik T.F., Puyan F.O., Sezer A., et al. Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism. Ann Nucl Med 19 (2005) 387-392
19. 99mTc-MIBI in functional studies of the parathyroid gland?. Nephrol Dial Transplant 13 suppl 3 (1998) 33-36
20. 99mTc-sestamibi scintigraphy in chronic haemodialysis patients: static and dynamic explorations. Nephrol Dial Transplant 15 (2000) 1201-1206
21. 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun 24 (2003) 755-762
22. 99mTc-methoxyisobutilisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. Worl J Surg 28 (2004) 100-107
23. Spanu A., Falchi A., Manca A., et al. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med 45 (2004) 40-48
24. Royal R.E., Delpassand E.S., Shapiro S.E., et al. Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. Surgery 132 (2002) 968-974